Hongmei Chen is the founder and partner of Laurel International. As one of the first batch of college students in China, I have held executive level positions in foreign companies and listed companies in the 1990s. I obtained an Australian MBA degree in 2003 and founded Laurel International in 2004. After that, to help the development of overseas Chinese, I founded the Invest Australia Association and the 1818 Club. In 2013, I was awarded the "Outstanding Chinese Business Elite Award" by the then Prime Minister Kevin Rudd. I have been actively participating in and launching philanthropy activities, including the Monash University GIG Scholarship Program, sponsoring the Diabetes Research Team of Monash University, sponsoring the Melbourne Symphony Orchestra, establishing the Invest Australia scholarship program, and supporting the epidemic affected areas.

陈红梅，是桂冠国际创始人、合伙人。作为中国最早几批大学生之一，90年代已在外企和上市公司担任要职。2003年获得澳洲MBA文凭，并于2004年创办桂冠国际集团，之后更是关心海外华人发展而创办创业澳洲协会和1818俱乐部。2013年被授予由当时总理陆克文颁发的 “杰出华裔商业精英奖” 。并且一直积极参与、发起慈善活动，包括莫纳什大学GIG奖学金计划，赞助莫纳什大学糖尿病研究团队，赞助墨尔本交响乐团MSO，创办创业澳洲奖学金项目，支援灾区等。

Mr. LAN Fusheng is the founder of Guilin GFS Monk Fruit Corporation and Guilin Dadi Biotech. Co., Ltd., and he is also the director of the board, CEO, legal representative, chief technology officer of these two companies. He has been serving as visiting professor and master's tutor in 6 universities. He has been presiding or participated 46 national, provincial and municipal R&D projects and achieved 43 R&D achievements; he has published 57 scientific papers; he has also obtained 3 authorized Chinese invention patents and 22 international invention patents. He has received 33 honors at the national, provincial and ministerial levels in China. Under Mr. Lan Fusheng’s leadership, Guilin GFS Monk Fruit Corporation has won 62 awards and honors at the national, provincial and ministerial levels in China.

桂林吉福思罗汉果有限公司和桂林市大地生物技术有限公司创始人，现任董事、总裁、法人代表、首席技术官；先后任6所高校的客座教授和硕士研究生导师。先后主持或参加了46项国家、省、市下达的科研项目，获得43项科研成果；发表科技论文57篇，获授权的中国发明专利3项，其他国家/国际发明专利22项。个人先后荣获中国国家、省部级等荣誉33项，所领导的吉福思公司先后荣获中国国家、省部级等荣誉62项。

Jeffrey Tang is an INDUSTRIAL HEMP ENTREPRENEUR and LEGITIMATECANNABIS PIONEER since 2013 with a particular focus on Australasian Relations  and Opportunities. 

He is the CEO and Founder of Hemp Australia Pty Ltd. He is also the Non-Executive Director and Head of Asia for Botanic Wellness Limited.  

At a time when the merits of hemp to humankind and the environment had long been  forgotten, and even demonised by society (alongside its marijuana cousin), Jeffrey  has overcome the criticism of many people, especially his Chinese peers to emerge  as an active/dedicated proponent/supporter/promoter of the cannabis industry.  

Today, as one of a select few people in the hemp industry with a Chinese background,  Jeffrey continues to bridge relations between the Australian and Chinese hemp industries, and the wider international community to facilitate hemp education and  innovation, (international) academic exchange and quality hemp projects. As well, he  is a start-up venture capital investor and is skilled in negotiation, business planning  and development, investor relations, international business, and global sourcing. 

Jeffrey believes that the cannabis industry is unique like no other with the potential and power to change, and save the planet. His goal and vision is to raise awareness  of this complex and fast-growing industry, and to develop healthy, high quality and  environmentally sustainable hemp/cannabis products to benefit society whilst protecting our precious, fragile planet at such a critical time. 

Jeffrey Tang 自 2013 年以来一直是工业大麻和合法大麻产业的企业家先锋，尤其专注于澳大利亚和亚太工业大麻行业的发展和契机。他是汉麻澳洲（Hemp Australia）的 创始人和首席执行官，也是 Botanic Wellness Limited 的非执行董事兼亚洲负责人。在人们早已忘记了大麻对人类和环境的好处，甚至被主流社会长期广泛定义为非法并妖魔化的情况下，Jeffrey 承受并克服了许多人，尤其包括亲人和朋友的批评和质疑， 他成为中国同龄人之中最活跃的工业大麻行业奉献者，支持者和促进者。如今，作为工业/药用大麻行业世界范围内少数拥有中国背景的几个人之一，Jeffrey 持续增进澳大利亚，中国以及世界工业大麻行业的交流，以促进大麻行业教育和创新， 并与更广泛的国际社会建立架起沟通的桥梁，参与（国际）学术交流和优质大麻项目。同时，他还是一个独具慧眼的新兴行业风险投资人，擅长谈判、业务规划和开发、投资者关系、国际贸易业务和全球采购。Jeffrey 认为，大麻产业具有独一无二的，改变和拯救地球的潜力和力量。他的目标和愿景是提高人们对这个复杂且快速增长行业的认识，并开发健康，优质和使环境可持续发展的工业大麻产品，在这一至关重要的时刻，保护我们珍贵的脆弱星球并同时造福社会。

An entrepreneur, researcher and consultant, Daisy founded her own businesses Insight Data Technologies (China) and InSight4 Analytica (Australia) in the field of workforce analytics and planning services, following her fifteen years of professional experiences with prestigious global consulting firms, Mercer Management Consulting, Ipsos, and TNS Global. 

Daisy has demonstrated her domain expertise and thought leadership in data science and digital technology applied in management field through driving long-term product and service innovations in human resource management, mostly in China (while now starting to reach out across the Asia Pacific regions). 

In October 2018, with a series of uniquely-positioned analytical product services launched to the market, InSight Data Technologies won The Best Product of China HRTech Awards. During the following years, the Company was certified as China High and New Technology Enterprises by the Ministry of Science and Technology, Ministry of Finance, and State Administration of Taxation, P.R.China, as well as Zhong Guan Cun High and New Technology Enterprises Awards. 

Daisy had her MBA  with The University of Queensland. Her professional achievement has made her recognized as Distinguished Global Talent by Beijing Government of China. She also sits at the Technical Management Board of China Council for Promotion of International Trade (CCPIT), for international standards development and reviews in human resource management field. 

许女士是六点一刻创始人和析源数据科技CEO，创建了业内领先的组织健康和人效监测系统，通过人力资源数字化管理和智能决策体系，帮助企业快速诊断组织效率并建立管理提升路径。创业前，许女士有超过15年的战略咨询和人力资源管理咨询经验，曾在全球顶尖的管理咨询和市场研究公司任职，如美世咨询（Mercer），Ipsos, 和TNS Global.

许女士在管理咨询领域运用数据科学和科技工具方面建立了领域声望，并一直引领中国人力资源科技产品和服务的不断创新。在许女士的领导下，析源数据科技推出了一系列具有开创意义的人力资本分析和规划领域的科技产品，并在2018年凭借“组织健康和人效监测系统”的成功推出，获得了中国HRTech最佳产品奖；在2019-2020年，公司还连续获得国家高新技术企业认证，和中关村高新技术企业认证。

许女士拥有澳大利亚昆士兰大学MBA学位，2015年被评为北京市朝阳区首批认定国际高端商务人才；2020年入选中国贸促会行业委员会人力资源管理与人力资本评价标准化技术委员会（CCPITCSC/TC 6)专家委员，参与国际人力资本评价标准的制定和评审工作。

Su Zhang is not only a young and successful female CEO of an ASX-listed pharmaceutical manufacturing company (Star Combo Pharma), but she is also a qualified pharmacist.

Su has over 15 years’ experience in the pharmaceutical and supplement sectors with previous roles at Terry White Chemist and Abbott Australia (as a Senior Drug Safety Associate and Asia Pacific Regional Manager)

Under Su zhang’s leadership, Star Combo Pharma has experienced steady organic revenue growth and achieved important milestones including:

• Successfully listing the company on the ASX in 2018

• Recently completed a private placement of $33M – welcoming a large investment company as a strategic and significant shareholder

• Su was instrumental in securing the purchase of a new 20,000 square meter factory site where she will install 13 new production lines and a research and development centre – the aim of this deal is to ensure the company is able to expand their manufacturing capabilities to become Australia’s leading manufacturer in the health supplement space

• Su successfully led the application process for the company to become a TGA certified soft capsule manufacturer, resulting in Star Combo Pharma now having a full set of TGA certification qualifications including powder, liquid, soft capsule, hard capsule, and gummy vitamins

• Su set up a major partnership with Terry White Chemist, giving them exclusive rights to sell the companies ‘Living Healthy’ brand

Su Zhang不仅是一位年轻并且成功的大型制药上市企业（Star Combo Pharma）的女性首席执行官， 更是一名优秀的药剂师。

Su在医药保健领域拥有超过15年的经验，曾在Terry White 药房和雅培澳洲担任资深药物安全顾问和亚太区经理。

在Su zhang的领导下，Star Combo Pharma经历了稳定的内部收入增长，并取得了重要的里程碑，包括：

• 2018年成功在ASX上市
  

• 最近完成了3,300万澳币的私募，成功和一家大型投资公司成为战略性合作伙伴

• 购买了新的20,000平方米新工厂厂址，在那里将安装13条新生产线和一个研发中心，确保公司能够扩展生产产能，目标成为澳大利亚保健品领域的领先制造商。

• Su成功领导了公司的TGA申请流程，成为TGA认证的软胶囊制造商，到现在Star Combo Pharma拥有全套TGA认证资格，包括粉剂，液体，软胶囊，硬胶囊和软糖维生素

• Su与Terry White Chemist建立了重要的合作伙伴关系，达成了在澳洲450家药房独家销售“ Living Healthy”品牌的合作协议。